Parenteral administration of dialkyl dialkyl ammonium halides to prevent bacterial and viral infections following organ graft surgery

摘要

Use of a dialkyl dialkyl ammonium halide in parenteral medicines given over 1 to 8 days to prevent bacterial and viral infections following a graft surgery. The dialkyl dialkyl ammonium halide is preferably didecyl dimethyl ammonium chloride Bardac (RTM), and it is given at a unit dosage of 150 mg.